Profile image
Story Views

Last Hour:
Last 24 Hours:

Pruritus Pipeline Global Therapeutics Market Pipeline Review Report H2 2016

Monday, January 9, 2017 5:07
% of readers think this story is Fact. Add your two cents.

Headline: Bitcoin & Blockchain Searches Exceed Trump! Blockchain Stocks Are Next!

Pruritus – Pipeline Review, H2 2016 - The report provides comprehensive information on the therapeutics under development for Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects.

Complete report on Pruritus – Pipeline Review, H2 2016 with 44 Tables and 16 Figures, Spread across 123 pages is available at

Major Points Covered in Table of Contents

  • Pruritus – Companies Involved in Therapeutics Development
  • Pipeline Products for Pruritus – Comparative Analysis
  • Pruritus – Therapeutics under Development by Companies
  • Pruritus – Therapeutics under Investigation by Universities/Institutes
  • Pruritus – Pipeline Products Glance
  • Pruritus – Products under Development by Companies
  • Pruritus – Products under Investigation by Universities/Institutes

Companies Discussed In This Report:

Albireo, Alveonix, Amorepacific Corporation, Asana BioSciences, Cara Therapeutics, Chugai Pharmaceutical Co., Creabilis SA, ELORAC, Inc., Faes Farma, GlaxoSmithKline Plc, Hydra Biosciences, LEO Pharma A/S, Merck & Co., NeRRe Therapeutics Ltd Nippon Shinyaku Co., Patara Pharma, Phosphagenics Limited, RDD Pharma Ltd. , Sanwa Kagaku Kenkyusho Co., Shionogi & Co., Sumitomo Dainippon Pharma Co., Teikoku Pharma USA, Tioga Pharmaceuticals, Trevi Therapeutics, Vanda Pharmaceuticals Inc.

Inquire on the Report at

Drug Profile Discussed In This Report:

A-4250, aprepitant asimadoline , ASN-008, Ax-10 , Ax-8, bilastine , cromolyn sodium, CT-327, CT-340, desloratadine, difelikefalin, GSK-2330672, lidocaine hydrochloride, nalbuphine hydrochloride ER, naloxone hydrochloride , nemolizumab, NS-141 , orvepitant maleate, PAC-14028, Peptides to Target TRPV1 for Pain and Itch, RDD-160, serlopitant , SK-1405, Small Molecule to Agonize CB2 for Pruritus, Small Molecule to Inhibit Substance P for Pruritus , Small Molecules to Antagonize Mas-Related G-Protein Coupled Receptor for Pruritus, Small Molecules to Antagonize TRPV3 for Pruritus and Psoriasis, Small Molecules to Block NaV1.7 Channel for Pain, Ocular Pain and Pruritus TPU-010 tradipitant 

The report provides a snapshot of the global therapeutic landscape of Pruritus. The report reviews pipeline therapeutics for Pruritus by companies and universities/research institutes based on information derived from company and industry-specific sources .The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages .The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities .

The report reviews key player’s involved Pruritus therapeutics and enlists all their major and minor projects. The report assesses Pruritus therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type .The report summarizes all the dormant and discontinued pipeline projects .The report reviews latest news related to pipeline therapeutics for Pruritus.

Purchase a Copy of Report at: OR Get a DISCOUNT at

Reasons to buy
Gain strategically significant competitor information, analysis, and insights to formulate effective     R&D strategies. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Identify and understand important and diverse types of therapeutics under development for Pruritus Identify potential new clients or partners in the target demographic.

Develop strategic initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics. Devise corrective measures for pipeline projects by understanding Pruritus pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Explore Other Reports on Pharmaceuticals Market at

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. 

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.